| Title | Mild cognitive impairment. |
| Publication Type | Journal Article |
| Year of Publication | 2006 |
| Authors | Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B |
| Corporate Authors | International Psychogeriatric Association Expert Conference on mild cognitive impairment |
| Journal | Lancet |
| Volume | 367 |
| Issue | 9518 |
| Pagination | 1262-70 |
| Date Published | 2006 Apr 15 |
| ISSN | 1474-547X |
| Keywords | Aged, Cholinergic Antagonists, Clinical Trials as Topic, Cognition Disorders, Dementia, Disease Progression, Humans, Memory, Severity of Illness Index |
| Abstract | Mild cognitive impairment is a syndrome defined as cognitive decline greater than expected for an individual's age and education level but that does not interfere notably with activities of daily life. Prevalence in population-based epidemiological studies ranges from 3% to 19% in adults older than 65 years. Some people with mild cognitive impairment seem to remain stable or return to normal over time, but more than half progress to dementia within 5 years. Mild cognitive impairment can thus be regarded as a risk state for dementia, and its identification could lead to secondary prevention by controlling risk factors such as systolic hypertension. The amnestic subtype of mild cognitive impairment has a high risk of progression to Alzheimer's disease, and it could constitute a prodromal stage of this disorder. Other definitions and subtypes of mild cognitive impairment need to be studied as potential prodromes of Alzheimer's disease and other types of dementia. |
| DOI | 10.1016/S0140-6736(06)68542-5 |
| Alternate Journal | Lancet |
| PubMed ID | 16631882 |
Related Institute:
Brain Health Imaging Institute (BHII)